Stanley Lapidus serves as Chief Executive Officer at SynapDx. He was an Advisor of Health IQ. He also serves as Chief Executive Officer at Lapidx Associates. Lapidus co-founded and served as President, Chief Executive Officer and Board Member at SynapDx. Lapidus is also the Co-Founder and Chief Executive Officer at Helicos Biosciences. He has been an Executive Chairman of the firm since October 2007 and also served as its President. Lapidus is an experienced life-science entrepreneur. He serves as a Venture Advisor at Flagship Ventures. He founded EXACT Sciences in 1995 and served as its President from 1995 to 2000. He served as Board Member at Daktari Diagnostics. Lapidus served as a Director of EXACT from February 1995 to July 21, 2006 and its Chairman since May 2000. Prior to EXACT Sciences, he founded Cytyc and served as the President and Chief Executive Officer from 1987 to 1994. Lapidus also founded Itran. He is a Member of Business Advisory Board at Excel Medical Ventures. Lapidus has been the Chairman of Precision Therapeutics, since August 2003 and its Director since October 2001. He serves as the Chairman of Valeo Business Advisory Board for Valeo Medical. Lapidus served as Director of TransMedics. He serves as an Advisor of the Harvard MIT Division of Health Services and Technology. Lapidus has been Research Assistant Professor in the Pathology Department of Tufts University Medical School, Boston since 1994. He serves as a Senior Lecturer of MIT's Sloan School and a Lecturer of Harvard Medical School. Lapidus served as Member of the Advisory Board for Cooper Union School of Engineering since 1999. He served as Member of Advisory Board for the Harvard School of Public Health's Center for Cancer Prevention since 1995. Lapidus holds a B.S. Degree in Electrical Engineering from Cooper Union. He is the Board member at Fractyl. He also serves as a Board Member at PathAI. He served as Industry Advisor at Flare Capital Partners. He also serves as Board Member at T2 Biosyste [Source: Public Company Filing]